Glucagon: Structure-Function Relationships Investigated by Sequence Deletions
- 1 January 1981
- journal article
- research article
- Published by Walter de Gruyter GmbH in Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie
- Vol. 362 (1) , 665-678
- https://doi.org/10.1515/bchm2.1981.362.1.665
Abstract
A series of glucagon analogs, des-(1-4)-glucagon, des-(5-9)-glucagon, des-(10-15)-glucagon, des-(16-21)-glucagon, des-(22-26)-glucagon and des-(27-29)-glucagon, were prepared by condensation of synthetic fragments and characterized biologically and immunologically. Fully synthetic glucagon was also characterized. The potencies with regard to glucagon receptor binding in purified rat liver plasma membranes were, in decreasing order: synthetic glucagon 108%, des-(1-4)-glucagon 5.7%, des-(27-29)-glucagon 0.92%, des-(5-9)-glucagon 0.47%, des-(10-15)-glucagon 0.0028%, des-(16-21)-glucagon 0.0017% and des-(22-26)-glucagon 0.00060% relative to that of natural porcine glucagon. Des-(27-29)-glucagon was the only analog that activated the adenylate cyclase in rat liver plasma membranes or stimulated the lipolysis in isolated free fat cells from rat epididymal fat pad. The potencies were 0.16% and 0.20% of that of glucagon, respectively. Des(1-4)-glucagon was a glucagon antagonist in the adenylate cyclase assay. The immunoreactivities of the glucagon analogs were determined with 2 commonly used anti-glucagon sera, K 5563 and K 4023, directed towards the C-terminus and some segment in the sequence 2-23, respectively. In the K 5563 assay, des-(27-29)-glucagon and des-(22-26)-glucagon had potencies of 0.0009% and < 0.09% of that of glucagon, respectively. The remaining analogs had potencies varying from 45%-141% of that of glucagon. In the K 4023 assay, the analogs showed a non-linear dilution effect. The combined results indicate a partition within the glucagon molecule with regard to receptor binding and adenylate cyclase activation. The region 10-26 appears to be the most important for receptor binding, whereas 1-4 is essential for adenylate cyclase activation. The C-terminal segment 27-29 is important for the maintenance of full receptor binding but non-essential for adenylate cyclase activation.This publication has 21 references indexed in Scilit:
- Preparation and properties of glucagon analogs prepared by semi-synthesis from CNBr-glucagonBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- Immunogenicity and Bioactivity of Glucagon, Modified at Methionine-27Hormone and Metabolic Research, 1979
- Synthesis and properties of a photoaffinity probe for the glucagon receptor in hepatocyte plasma membranesBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- Labeling of glucagon binding components in hepatocyte plasma membranesBiochemical and Biophysical Research Communications, 1977
- Conformational transitions of glucagon in solution: The α → β transitionBiochemical and Biophysical Research Communications, 1977
- Glucagon structure and function. II. Increased activity of iodoglucagonBiochemical and Biophysical Research Communications, 1973
- Lipolytic Action of a Newly Isolated Vasoactive Intestinal PolypeptideHormone and Metabolic Research, 1973
- Purification of125I-Glucagon by Anion Exchange ChromatographyHormone and Metabolic Research, 1972
- Zur Synthese des Glucagons, XVII. Darstellung der Sequenz 7–29European Journal of Inorganic Chemistry, 1968
- The Amino Acid Sequence of Glucagon. V. Location of Amide Groups, Acid Degradation Studies and Summary of Sequential EvidenceJournal of the American Chemical Society, 1957